Do patients with device-detected atrial fibrillation and prior stroke benefit from anticoagulation?

In patients with device-detected atrial fibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. Paulus Kirchhof, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, in a late-breaking clinical trials session at the annual congress of the American Heart Rhythm Society (HRS 2024) held in Boston, U.S., May 16–19.

Related Keywords

Hamburg ,Germany ,Eppendorf ,Nordrhein Westfalen ,Paderborn ,Boston ,Massachusetts ,United States ,American ,Paulus Kirchhof ,Andreas Goette ,American Heart Rhythm Society ,University Medical Center Hamburg ,University Medical Center Hamburg Eppendorf ,Atrial High Rate ,Device Detected Sub Clinical Atrial Fibrillation ,Vincenz Hospital ,